Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; Ke, Hua; Madison, Russell; Drenth, Anne Paulien; van der Burg, Eline; Schut, Eva; Henneman, Linda; van Miltenburg, Martine H; Proost, Natalie; Zhen, Huiling; Wientjens, Ellen; de Bruijn, Roebi; de Ruiter, Julian R; Boon, Ute; de Korte-Grimmerink, Renske; van Gerwen, Bastiaan; Féliz, Luis; Abou-Alfa, Ghassan K; Ross, Jeffrey S; van de Ven, Marieke; Rottenberg, Sven; Cuppen, Edwin; Chessex, Anne Vaslin; Ali, Siraj M; Burn, Timothy C; Jimenez, Connie R; Ganesan, Shridar; Wessels, Lodewyk F A; Jonkers, Jos
(2022) Nature, volume 609, issue 7929, pp. E13 - E13
(Comment)
Abstract
Correction to: Nature https://doi.org/10.1038/s41586-022-05066-5 Published online 10 August 2022
show less
Download/Full Text
Keywords: General, Published Erratum
ISSN: 0028-0836
Publisher: Nature Publishing Group
Note: Publisher Copyright: © The Author(s) 2022. Publisher Copyright: © 2022, The Author(s).
(Peer reviewed)